ExLibris header image
SFX Logo
Title: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
Source:

Elife [2050-084X] Joseph, James yr:2016


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Shin, I. "Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 Cells." IUBMB life 58.11 (2006): 664-9. Link to Full Text for this item Link to SFX for this item
2. Fernig, D. "Differential regulation of FGF-1 and-2 mitogenic activity is related to their kinetics of binding to heparan sulfate in MDA-MB-231 human breast cancer cells." Biochemical and biophysical research communications 267.3 (2000): 770-776. Link to Full Text for this item Link to SFX for this item
3. Wai-Sum, W.-S. u. "Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway." The Journal of steroid biochemistry and molecular biology 108.1 (2008): 64-71. Link to SFX for this item
4. Bevilacqua, A. "Post-transcriptional regulation of gene expression by degradation of messenger RNAs." Journal of cellular physiology 195.3 (2003): 356-372. Link to Full Text for this item Link to SFX for this item
5. Battersby, S. "Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle." Reproduction 127.1 (2004): 79-86. Link to SFX for this item
6. Moy, B. "TEACH: Tykerb evaluation after chemotherapy." Clinical breast cancer 7.6 (2007): 489-92. Link to SFX for this item
7. Delpuech, O. "Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression." Molecular and cellular biology 27.13 (2007): 4917-30. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced